1106 related articles for article (PubMed ID: 17762545)
21. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
Schonberg MA; Davis RB; Wee CC
Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
[TBL] [Abstract][Full Text] [Related]
22. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
Lakoski SG; Herrington DM
Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
[TBL] [Abstract][Full Text] [Related]
23. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
[TBL] [Abstract][Full Text] [Related]
24. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
25. Hormone therapy and coronary heart disease in young women.
Weiner MG; Barnhart K; Xie D; Tannen RL
Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
27. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
28. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
Derry PS
Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
[TBL] [Abstract][Full Text] [Related]
30. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
[TBL] [Abstract][Full Text] [Related]
31. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
32. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
33. Preserving cardiovascular benefits of hormone replacement therapy.
Bush TL
J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
[TBL] [Abstract][Full Text] [Related]
34. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
35. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
McPherson R
Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone therapy and the cardiovascular system.
Speroff L; Lobo RA
Heart Dis Stroke; 1994; 3(3):173-6. PubMed ID: 8044433
[No Abstract] [Full Text] [Related]
37. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
39. Postmenopausal hormone therapy and cardiovascular disease in women.
Stefanick ML
Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177
[TBL] [Abstract][Full Text] [Related]
40. Estrogens, lipids, and heart disease.
Barrett-Connor E; Miller V
Clin Geriatr Med; 1993 Feb; 9(1):57-67. PubMed ID: 8443740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
